Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by NeurAxis, Inc.

NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024
From NeurAxis, Inc.
Via GlobeNewswire
NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024
From NeurAxis, Inc.
Via GlobeNewswire
NeurAxis Reports Second Quarter 2024 Financial Results
From NeurAxis, Inc.
Via GlobeNewswire
NeurAxis to Host Second Quarter 2024 Results and Business Update Call on Friday, August 9, 2024
From NeurAxis, Inc.
Via GlobeNewswire
NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure
From NeurAxis, Inc.
Via GlobeNewswire
NeurAxis Reports First Quarter 2024 Financial Results
From NeurAxis, Inc.
Via GlobeNewswire
NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
From NeurAxis, Inc.
Via GlobeNewswire
NeurAxis Announces New Medical Policy Coverage For Nearly Six Million Lives in Florida
From NeurAxis, Inc.
Via GlobeNewswire
NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024
From NeurAxis, Inc.
Via GlobeNewswire
NeurAxis Announces New Medical Policy Coverage in North Dakota
From NeurAxis, Inc.
Via GlobeNewswire
NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results
From NeurAxis, Inc.
Via GlobeNewswire
NeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024
From NeurAxis, Inc.
Via GlobeNewswire
NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center Registry
From NeurAxis, Inc.
Via GlobeNewswire
NeurAxis Announces Highmark BCBS Policy Coverage
From NeurAxis, Inc.
Via GlobeNewswire
NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy Coverage
From NeurAxis, Inc.
Via GlobeNewswire
NeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services Conference
From NeurAxis, Inc.
Via GlobeNewswire
NeurAxis Appoints Timothy Henrichs as Chief Financial Officer
From NeurAxis, Inc.
Via GlobeNewswire
NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive Officer
From NeurAxis, Inc.
Via GlobeNewswire
NeurAxis Reports Third Quarter 2023 Financial Results
From NeurAxis, Inc.
Via GlobeNewswire
NeurAxis Announces CareFirst BCBS Policy Coverage
From NeurAxis, Inc.
Via GlobeNewswire
NeurAxis Secures $3 Million Financing
From NeurAxis, Inc.
Via GlobeNewswire
NeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal Device
From NeurAxis, Inc.
Via GlobeNewswire
NeurAxis Announces Results of Comparative Study of IB-Stim™ and Standard Medical Therapy in Adolescents with Functional Abdominal Pain Disorders
From NeurAxis, Inc.
Via GlobeNewswire
NeurAxis Reports Second Quarter 2023 Financial Results
From NeurAxis, Inc.
Via GlobeNewswire
NeurAxis to Present at the Gilmartin Group Emerging Growth Showcase
From NeurAxis, Inc.
Via GlobeNewswire
NeurAxis Announces Publication of Prospective Study Showing IB-Stim™ Improves Quality of Life of Adolescents with IBS
From NeurAxis, Inc.
Via GlobeNewswire
NeurAxis Highlights Pediatric Post-Concussion Clinical Study
From NeurAxis, Inc.
Via GlobeNewswire
NeurAxis Highlights Strength of its Board of Directors
From NeurAxis, Inc.
Via GlobeNewswire
NeurAxis Highlights Two Independent Studies Showing Benefits of IB-Stim in Adolescents Involving the Gut Microbiome
From NeurAxis, Inc.
Via GlobeNewswire
NeurAxis Announces Over $8 Million in IB-Stim™ Revenue
From NeurAxis, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.